IFNG and cancer: Cancer cells in particular exhibited a substantially weaker interferon gamma response post treatment in growing ribociclib-resistant tumors compared to ribociclib-sensitive shrinking tumors (Fig. 5F top) (est = −0.027, df = 1913, t = −20.2, p < 0.0001).